Your Article Summary
See Latest ArticlesBoehringer Ingelheim receives positive recommendation from European scientific committee for a new once daily Mirapexin (pramipexole) formulation for the treatment of Parkinson's disease
Boehringer Ingelheim, 06/29/09
AVI BioPharma, Inc. , a developer of RNA-based drugs, announced that immediately following the close of the U.S. markets it will join the broad-market Russell 3000 Index following Russell Investments' annual reconstitution of its comprehensive set of U.S. and global equity indexes.
Today in Conferences/Meetings...keeping you current
Receive free subspecialty "5-minute updates" via email
ImmunoGen, Inc. Announces Conference Call to Discuss Clinical Data Reported at Recent Medical Meetings
ImmunoGen, Inc., 12/04/09
Allos Therapeutics to Launch Global Registry for Patients with Peripheral T-Cell Lymphoma at the American Society of Hematology Annual Meeting
Allos Therapeutics, 12/04/09
Cytokinetics Announces Non-Clinical Data Relating to GSK-923295 to be Presented at the 32nd Annual San Antonio Breast Cancer Symposium
Cytokinetics, 12/04/09
Today in Medical Devices/Products...keeping you current
Receive free subspecialty "5-minute updates" via email
New Amgen Scholars Web site Launches to Build a Global Network for Future Scientists
Amgen, 12/04/09
Genzyme Begins Shipping Newly Produced Cerezyme from Allston Plant
Genzyme, 12/02/09
Bayer's Betaferon approved in China for Treatment of Multiple Sclerosis
BayNews International, 12/02/09
Today in Research & Development...keeping you current
Receive free subspecialty "5-minute updates" via email
New Amgen Scholars Web site Launches to Build a Global Network for Future Scientists
Amgen, 12/04/09
Bayer Team wins the “Deutscher Zukunftspreis” awarded by the German President
BayNews International, 12/03/09
GSK Update: GSKs Arepanrix H1N1 pandemic vaccine prequalified by the World Health Organization
GlaxoSmithKline, 12/02/09